Pharmacology of voltage-gated and calcium-activated potassium channels

Current Opinion in Chemical Biology

Volumn 3, Issue 4, 1999, Pages 448-458

  Kaczorowski, Gregory J ^a   Garcia, Maria L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; ION CHANNEL; POTASSIUM; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL STIMULATING AGENT; VOLTAGE GATED CHANNEL FORMING PROTEIN;

BACTERIUM; CRYSTAL STRUCTURE; ION CONDUCTANCE; NONHUMAN; PHARMACOLOGY; REVIEW;

BACTERIA (MICROORGANISMS);

EID: 0033178906     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1367-5931(99)80066-0     Document Type: Article

References (87)

1. Bargmann CL: Neurobiology of the Caenorhabditis elegans genome. Science 1998, 282:2028-2033. This paper describes the wide variety of ion channels present in the C. elegans genome.
2. + channels: More than model behavior. Trends Pharmacol Sci 1997, 18:474-483.
3. + conduction and selectivity. Science 1998, 280:69-77. This paper describes the first crystal structure of a potassium channel protein, which explains ion selectivity and conduction.
4. Christie MJ, North RA, Osborne PB, Douglas J, Adelman JP: Heteropolymeric potassium channels expressed in Xenopus oocytes from cloned subunits. Neuron 1990, 4:405-411.
5. Isacoff EY, Jan YN, Jan LY: Evidence for the formation of heteromultimeric potassium channels in Xenopus oocytes. Nature 1990, 345:530-534.
6. Ruppersberg JP, Schroeter KH, Sakmann B, Stocker M, Sewing S, Pongs O: Heteromultimeric channels formed by rat brain potassium-channel proteins. Nature 1990, 345:535-537.
7. Hopkins WF: Toxin and subunit specificity of blocking affinity of three peptide toxins for heteromultimeric, voltage-gated potassium channels expressed in Xenopus oocytes. J Pharmacol Exp Therap 1998, 285:1051-1060.
8. + channels altered by presence of β-subunit. Nature 1994, 369:289-294.
9. + channels. J Biol Chem 1997, 272:24371-24379.
10. + channel activity by the Kv8.1 subunit. J Biol Chem 1997, 272:8774-8780.
11. Garcia ML, Hanner M, Knaus H-G, Koch R, Schmalhofer W, Slaughter RS, Kaczorowski GJ: Pharmacology of potassium channels. Adv Pharmacol 1997, 39:425-471.
12. + channels. Toxicon 1998, 36:1641-1650.
13. Swartz KJ, MacKinnon R: An inhibitor of the Kv2.1 potassium channel isolated from the venom of a Chilean tarantula. Neuron 1995, 15:941-949.
14. Diochot S, Schweitz H, Beress L, Lazdunski M: Sea anemone peptides with a specific blocking activity against the fast inactivating potassium channel Kv3.4. J Biol Chem 1998, 273:6744-6749.
15. Sanguinetti MC, Johnson JH, Hammerland LG, Kelbaugh PR, Volkmann RA, Saccomano NA, Mueller AL: Heteropodatoxins: Peptides isolated from spider venom that block Kv4.2 potassium channels. Mol Pharmacol 1997, 51:491-498.
16. + channel-blocking peptides. Neuron 1995, 15:5-10.
17. Slaughter RS, Garcia ML, Kaczorowski GJ: Ion channels as drug targets in the immune system. Curr Pharm Design 1996, 2:610-623.
18. Price M, Lee SC, Deutsch C: Charybdotoxin inhibits proliferation and IL2 production in human peripheral blood lymphocytes. Proc Natl Acad Sci USA 1989, 86:10171-10175.
19. + channels depolarize human T lymphocytes: Mechanism of the antiproliferative effect of charybdotoxin. Proc Natl Acad Sci USA 1992, 89:10094-10098.
20. Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ, Garcia ML: Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem 1993, 268:18866-18874.
21. v1.3 expressed in CHO cells. Biochemistry 1997, 36:3737-3744.
22. + channels. J Biol Chem 1997, 272:27577-27581.
23. Lin CS, Boltz RC, Blake JT, Nguyen M, Talento A, Fischer PA, Springer MS, Sigal NH, Slaughter RS, Garcia ML et al.: Voltage-gated potassium channels regulate calcium-dependent pathways involved in human T lymphocyte activation. J Exp Med 1993, 177:637-645.
24. Koo GC, Blake JT, Talento A, Nguyen M, Lin S, Sirotina A, Shah K, Mulvany KDH Jr, Cunningham P, Wunderler DL et al.: Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo. J Immunol 1997, 158:5120-5128.
25. + channel revealed by the NMR-derived structures of scorpion toxins. Neuron 1995, 15:1169-1181.
26. v1 family members.
27. + channels from Leiurus quinquestriatus var. hebraeus venom. Biochemistry 1994, 33:6834-6839.
28. + channel pore through mutant cycles with a peptide inhibitor. Science 1995, 268:307-310.
29. Gross A, Abramson T, MacKinnon R: Transfer of the scorpion toxin receptor to an insensitive potassium channel. Neuron 1994, 13:961-966.
30. MacKinnon R, Cohen SL, Kuo A, Lee A, Chait BT: Structural conservation in prokaryotic and eukaryotic potassium channels. Science 1998, 280:106-109. This paper demonstrates that the pore of potassium channels is a highly conserved structure.
31. Dufton MJ, Harvery AL: Dendrotoxins: How does structure determine function? J Toxicol Toxin Rev 1998, 17:161-182.
32. + channels in bovine brain. Biochemistry 1994, 33:1617-1623.
33. + channel Kv1 subtypes in synaptic membranes from bovine brain. Biochemistry 1997, 36:8195-8201.
34. Gasparini S, Danse JM, Lecoq A, Pinkasfeld S, Zinnjustin S, Young LC, de Medeiros CCL, Rowan EG, Harvey AL, Menez A: Delineation of the functional site of alpha-dendrotoxin. J Biol Chem 1998, 273:25393-25403.
35. Norton RS: Structure and function of peptide and protein toxins from marine organisms. J Toxicol Toxin Rev 1998, 17:99-130.
36. 22, a potent Kv1.3-specific immunosuppressive polypeptide. J Biol Chem 1998, 273:32697-32707.
37. Suarez-Kurtz G, Vianna-Jorge R, Pereira BF, Garcia ML, Kaczorowski GJ: Peptidyl blockers of Shaker-type Kv1 channels elicit twitches in guinea pig ileum by blocking Kv1.1 at the enteric nervous system and enhancing acetylcholine release. J Pharmacol Exp Therap 1999, 289:1517-1522.
38. Michne WF, Miles JW, Treasurywala AM, Castonguay LA, Weigelt C, Oconnor B, Volberg WA, Grant AM, Chadwick CC, Kraft DS, Hill RJ: Novel inhibitors of potassium ion channels on human T lymphocytes. J Med Chem 1995, 38:1877-1883.
39. + channels in human T lymphocytes. Mol Pharmacol 1995, 48:98-104.
40. Nguyen A, Kath JC, Hanson DC, Dethlefs B, Gutman G, Cahalan MD, Chandy KG: A novel class of potent organic blockers of the T-cell K channel, Kv1.3, that are selective for histidine 404. Biophys J 1996, 70:A446.
41. Nguyen A, Kath JC, Hanson DC, Biggers MS, Canniff PC, Donovan CB, Mather RJ, Bruns MJ, Rauer H, Aiyar J et al.: Novel nonpetide agents potently block the C-type inactivated conformation of Kv1.3 and suppress T cell activation. Mol Pharmacol 1996, 50:1672-1679.
42. + channels. Biophys J 1997, 72:A364.
43. Burgess LE, Koch K, Cooper K, Biggers MS, Ramchandani M, Smitrovich JH, Gilbert EJ, Bruns MJ, Mather RJ, Donovan CB, Hanson DC: The SAR of UK-78,282: A novel blocker of human T cell Kv1.3 potassium channels. Bioorg Med Chem Lett 1997, 7:1047-1052.
44. Goetz MA, Hensens OD, Zink DL, Borris RP, Morales F, Tamayo-Castillo G, Slaughter RS, Felix J, Ball RG: Potent nor-triterpenoid blockers of the voltage-gated potassium channel Kv1.3 from Spachea correae. Tetrahedron Lett 1998, 39:2895-2898.
45. v1 family potassium channels that will be useful as a biochemical, pharmacological and physiological probe of ion channel structure and function.
46. v1 family potassium channels: Mapping the domain of high affinity interaction. J Biol Chem 1999, in press.
47. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997, 80:772-781.
48. Kalman K, Nguyen A, Tsen-Crank J, Dukest ID, Chandy G, Hustad CM, Copeland NG, Jenkins NA, Mohrenweiser H, Brandriff B et al.: Genomic organization, chromosomal localization, tissue distribution, and biophysical characterization of a novel mammalian Shaker-related voltage-gated potassium channel, Kv1.7. J Biol Chem 1998, 273:5851-5857.
49. v1 family members.
50. Meiri N, Ghelardini C, Tesco G, Galeotti N, Dahl D, Tomsic D, Cavallaro S, Quattrone A, Capaccioli S, Bartolini A, Alkon DL: Reversible antisense inhibition of Shaker-like Kv1.1 potassium channel expression impairs associative memory in mouse and rat. Proc Natl Acad Sci USA 1997, 94:4430-4434.
51. Clark JD, Tempel BL: Hyperalgesia in mice lacking the Kv1.1 potassium channel gene. Neurosci Lett 1998, 251:121-124.
52. Brandt T, Strupp M: Episodic ataxia type 1 and 2 (familial periodic ataxia/vertigo). Audiol Neuro-otol 1997, 2:373-383.
53. Kohler M, Hirschberg B, Bond CT, Kinzie JM, Marrion NV, Maylie J, Adelman JP: Small-conductance, calcium-activated potassium channels from mammalian brain. Science 1996, 273:1709-1714.
54. Chandy KG, Fantino E, Wittekindt O, Kalman K, Tong L-L, Ho T-H, Gutman GA, Crocq M-A, Ganguli R, Nimgaonkar V et al.: Isolation of a novel potassium channel gene hSKCa3 containing a polymorphic CAG repeat: A candidate for schizophrenia and bipolar disorder? Mol Physchiat 1998, 3:32-37.
55. Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J: A human intermediate conductance calcium-activated potassium channel. Proc Natl Acad Sci USA 1997, 94:11651-11656.
56. Joiner WJ, Wang L-Y, Tang MD, Kaczmarek L: hSK4, a member of a novel subfamily of calcium-activated potassium channels. Proc Natl Acad Sci USA 1997, 94:11013-11018.
57. Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J: A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes. J Biol Chem 1997, 272:32723-32726.
58. c family channels.
59. Ca channel, IKCa1. J Biol Chem 1999, 274:5746-5754.
60. Kaczorowski GJ, Knaus H-G, Leonard RJ, McManus OB, Garcia ML: High conductance, calcium-activated potassium channels; structure, pharmacology and function. J Biomembr Bioenerg 1996, 28:255-267.
61. Joiner WJ, Tang MD, Wang L-Y, Dworetzky SI, Boissard CG, Gan L, Gribkoff VK, Kaczmarek LK: Formation of intermediate-conductance calcium-activated potassium channels by interaction of Slack and Slo subunits. Nat Neurosci 1998, 1:462-469.
62. + channel, a distinct member of voltage-dependent ion channels with seven N-terminal transmembrane segments (S0-S6), an extracellular N terminus, and an intracellular (S9-S10) C terminus. Proc Nat Acad Sci USA 1997, 94:14066-14071
63. Schreiber M, Salkoff L: A novel calcium-sensing domain in the BK channel. Biophys J 1997, 73:1355-1363.
64. + channels. J Gen Physiol 1997, 109:647-673.
65. vCaβ) of maxi K channels. FEBS Lett 1996, 382:84-88.
66. Diaz L, Meera P, Amigo J, Stefani E, Alvarez O, Toro L, Latorre R: Role of the S4 segment in a voltage-dependent calcium-sensitive potassium (hSlo) channel. J Biol Chem 1998, 273:32430-32436.
67. Garcia ML, Kaczorowski GJ: Pharmacology of high-conductance calcium-activated potassium channels. Curr Res Ion Channel Modul 1998, 3:213-220.
68. Hanner M, Vianna-Jorge R, Kamassah A, Schmalhofer WA, Knaus HG, Kaczorowski GJ, Garcia ML: The β subunit of the high conductance calcium-activated potassium channel; identification of residues involved in charybdotoxin binding. J Biol Chem 1998, 273:16289-16296.
69. Hanner M, Schmalhofer WA, Munujos P, Knaus H-G, Kaczorawski GJ, Garcia ML: The β subunit of the high conductance calcium-activated potassium channel contributes to the high affinity receptor for charybdotoxin. Proc Natl Acad Sci USA 1997, 94:2853-2858.
70. + channels: An additional transmembrane region at the N terminus. Proc Natl Acad Sci USA 1996, 93:14922-14927.
71. Wanner SG, Koch RO, Koschak A, Trieb M, Garcia ML, Kaczorowski GJ, Knaus H-G: High-conductance calcium-activated potassium channels in rat brain: Pharmacology, distribution, and subunit composition. Biochemistry 1999, 38:5392-5400.
72. + channels: A transmembrane β-subunit homolog. Proc Natl Acad Sci USA 1999, 96:4137-4142. This paper identifies a new BK channel β subunit.
73. Ding JP, Li ZW, Lingle CJ: Inactivating BK channels in rat chromaffin cells may arise from heteromultimeric assembly of distinct inactivation-competent and noninactivating subunits. Biophys J 1998, 74:268-289.
74. Giangiacomo KM, Garcia ML, McManus OB: Mechanism of iberiotoxin block of the large-conductance calcium-activated potassium channel from bovine aortic smooth muscle. Biochemistry 1992, 31:6719-6727.
75. Mullmann TJ, Munujos P, Garcia ML, Giangiacomo KM: Electrostatic mutations in iberiotoxin as a unique tool for probing the electrostatic structure of the maxi-K outer vestibule. Biochemistry 1999, 38:2395-2402.
76. + channels in rat brain: Targeting to axons and nerve terminals. J Neurosci 1996, 16:955-963.
77. 125l]Iberiotoxin-D19Y/Y36F, the first selective, high specific activity radioligand for high-conductance calcium-activated potassium channels. Biochemistry 1997, 36:1943-1952.
78. + channel blockers paspalitrem C and paxilline on mammalian smooth muscle. Eur J Pharmacol 1996, 314:123-128.
79. + channels. Biochemistry 1994, 33:5819-5828.
80. McManus OB, Harris GH, Giangiacomo KM, Feigenbaum P, Reuben JP, Addy ME, Burka JF, Kaczorowski GJ, Garcia ML: An activator of calcium-dependent potassium channels isolated from a medicinal herb. Biochemistry 1993, 32:6128-6133.
81. Giangiacomo KM, KamassAh A, Harris G, McManus OB: Mechanism of maxi-K channel activation by dehydrosoyasaponin-I. J Gen Physiol 1998, 112:485-501.
82. McManus OB, Helms LMH, Pallanck L, Ganetzky B, Swanson R, Leonard RJ: Functional role of the β subunit of high-conductance calcium-activated potassium channels. Neuron 1995, 14:1-20.
83. Hu S, Fink CA, Kim HS, Lappe RW: Novel and potent BK channel openers: CGS 7181 and its analogs. Drug Devel Res 1997,41:10-21.
84. + channels by novel benzimidazolone. Eur J Pharmacol 1994, 251:53-59.
85. Hewawasam P, Meanwell NA, Gribkoff VK, Dworetzky SI, Boissard CG: Discovery of a novel class of BK channel openers: Enantiospecific synthesis and BK channel opening activity of 3-(5-chloro-2-hydroxyphenyl)-1,3-dihydro-3-hydroxy-6-(trifluoromethyl)-2H-indol-2-one. Bioorg Med Chem Lett 1997, 7:1255-1260.
86. 2+-dependent large-conductance potassium channels: Pharmacophore search and physiological evaluation of flavonoids. Bioorg Med Chem Lett 1997, 7:759-762.
87. Olesen S-P, Mathiasen D, Christophersen P, Ahring PK, Johansen TE: The substituted diphenylurea NS 1608 activates the α-subunit of the human BK channel (hSlo). Biophys J 1996, 70:129a.